Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rank in Stocks #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Share Price
$115.67
Market Cap
$285.98B
Change (1 day)
1.30%
Change (1 year)
25.31%
Country
US
Trade Merck & Co., Inc. (MRK)

Category

Revenue for Merck & Co., Inc. (MRK)
Revenue in Dec 2025 TTM: $65.01B
According to Merck & Co., Inc. latest financial reports the company's current revenue (TTM) is $65.01B. In 2024 the company made a revenue of $64.17B an increase over the revenue in the year 2023 that was $60.12B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Merck & Co., Inc. from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $65.01B 0.00%
2025 $65.01B 1.31%
2024 $64.17B 6.74%
2023 $60.12B 1.40%
2022 $59.28B 21.72%
2021 $48.70B 17.31%
2020 $41.52B 6.13%
2019 $39.12B -7.50%
2018 $42.29B 5.41%
2017 $40.12B 0.79%
2016 $39.81B 0.78%
2015 $39.50B -6.48%
2014 $42.24B -4.08%
2013 $44.03B -6.84%
2012 $47.27B -1.62%
2011 $48.05B 4.48%
2010 $45.99B 67.66%
2009 $27.43B 15.00%
2008 $23.85B -1.44%
2007 $24.20B 6.90%
2006 $22.64B 2.84%
2005 $22.01B -4.18%
2004 $22.97B 2.17%
2003 $22.49B 4.85%
2002 $21.45B 1.16%
2001 $21.20B -47.48%
2000 $40.36B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$65.18B 0.26%
US
$58.74B -9.65%
GB
$94.19B 44.89%
US
$61.16B -5.92%
US
$56.15B -13.63%
CH